Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Volitionrx (VNRX) Non-Current Debt (2018 - 2025)

Volitionrx filings provide 8 years of Non-Current Debt readings, the most recent being $5.8 million for Q4 2025.

  • On a quarterly basis, Non-Current Debt rose 47.19% to $5.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $5.8 million, a 47.19% increase, with the full-year FY2025 number at $5.8 million, up 47.19% from a year prior.
  • Non-Current Debt hit $5.8 million in Q4 2025 for Volitionrx, up from $5.6 million in the prior quarter.
  • In the past five years, Non-Current Debt ranged from a high of $5.8 million in Q4 2025 to a low of $1.7 million in Q2 2022.
  • Median Non-Current Debt over the past 5 years was $2.8 million (2022), compared with a mean of $3.4 million.
  • Biggest five-year swings in Non-Current Debt: decreased 21.47% in 2022 and later surged 83.97% in 2024.
  • Volitionrx's Non-Current Debt stood at $2.3 million in 2021, then rose by 22.39% to $2.8 million in 2022, then skyrocketed by 30.43% to $3.6 million in 2023, then rose by 9.05% to $4.0 million in 2024, then skyrocketed by 47.19% to $5.8 million in 2025.
  • The last three reported values for Non-Current Debt were $5.8 million (Q4 2025), $5.6 million (Q3 2025), and $5.8 million (Q2 2025) per Business Quant data.